Cholesterol and cancer.
作者信息
Siperstein M D
出版信息
Trans Am Clin Climatol Assoc. 1970;81:107-18.
Abstract
摘要
相似文献
1
Cholesterol and cancer.胆固醇与癌症。
Trans Am Clin Climatol Assoc. 1970;81:107-18.
2
Cholesterol metabolism in rats bearing Morris hepatoma 7777.
Cancer Res. 1973 Aug;33(8):1870-4.
3
Metabolic controls in precancerous liver: defective control of cholesterol synthesis in rats fed N-2-fluorenylacetamide.
Eur J Cancer (1965). 1971 Oct;7(5):459-65. doi: 10.1016/0014-2964(71)90044-2.
4
The relationship of cholesterol biosynthesis to cancer.胆固醇生物合成与癌症的关系。
Trans Am Clin Climatol Assoc. 1972;83:156-64.
5
The role of cholesterol in malignancy.胆固醇在恶性肿瘤中的作用。
Prog Exp Tumor Res. 1978;22:275-316. doi: 10.1159/000401203.
6
Effects of dietary cholesterol on bile acid synthesis in liver and hepatomas.
Cancer Res. 1974 Mar;34(3):449-53.
7
Regulation of cholesterol biosynthesis in rat liver after the administration of N-2-fluorenylacetamide.给予N-2-芴基乙酰胺后大鼠肝脏中胆固醇生物合成的调节
Lab Invest. 1973 Jun;28(6):723-7.
8
Inhibition by plant growth retardants of cholesterol biosynthesis in slices of rat liver and hepatoma.
Aust J Biol Sci. 1971 Dec;24(6):1125-30. doi: 10.1071/bi9711125.
9
[Nuclear ribonucleic acids of cancer cells].[癌细胞的核糖核酸]
Vestn Akad Med Nauk SSSR. 1968;23(3):26-30.
10
Regulation of lipid metabolism in in vitro cultured minimal deviation hepatoma 7288C.体外培养的微小偏差肝癌7288C中脂质代谢的调控
Lipids. 1972 Feb;7(2):146-55. doi: 10.1007/BF02532603.
引用本文的文献
1
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy.甲羟戊酸途径，癌症治疗中的一个代谢靶点。
Front Oncol. 2021 Feb 25;11:626971. doi: 10.3389/fonc.2021.626971. eCollection 2021.
2
Cancer prevention and therapy through the modulation of the tumor microenvironment.通过调节肿瘤微环境进行癌症预防与治疗。
Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S199-S223. doi: 10.1016/j.semcancer.2015.02.007. Epub 2015 Apr 10.
3
Loss of feedback control of hydroxymethylglutaryl coenzyme A reductase in hepatomas.肝癌中羟甲基戊二酰辅酶A还原酶反馈控制的丧失。
Proc Natl Acad Sci U S A. 1971 Feb;68(2):315-7. doi: 10.1073/pnas.68.2.315.
本文引用的文献
1
Lipid metabolism and atherosclerosis.脂质代谢与动脉粥样硬化。
Am J Med. 1951 Aug;11(2):209-27. doi: 10.1016/0002-9343(51)90107-6.
2
Studies on the site of the feedback control of cholesterol synthesis.胆固醇合成反馈控制位点的研究。
J Clin Invest. 1960 Apr;39(4):642-52. doi: 10.1172/JCI104079.
3
DELETION OF THE CHOLESTEROL-NEGATIVE FEEDBACK SYSTEM IN LIVER TUMORS.肝脏肿瘤中胆固醇负反馈系统的缺失
Cancer Res. 1964 Aug;24:1108-15.
4
NEW PROSPECTS IN CANCER BIOCHEMISTRY.
Adv Enzyme Regul. 1963;1:279-308. doi: 10.1016/0065-2571(63)90026-8.
5
BIOGENETIC HYPOTHESES FOR AFLATOXIN.黄曲霉毒素的生物遗传假说
Nature. 1964 Apr 11;202:188. doi: 10.1038/202188a0.
6
Feedback inhibition of aspartate transcarbamylase in liver and in hepatoma.
Cancer Res. 1962 Nov;22:1246-51.
7
Feedback inhibition of purine biosynthesis in ascites tumor cells.腹水肿瘤细胞中嘌呤生物合成的反馈抑制
J Biol Chem. 1962 Aug;237:2631-5.
8
9
The biochemical approach to the cancer problem.解决癌症问题的生化方法。
Fed Proc. 1958 Jul;17(2):691-7.
10
Cholesterol synthesis by liver. III. Its regulation by ingested cholesterol.肝脏的胆固醇合成。III. 摄入胆固醇对其的调节。
J Biol Chem. 1953 Mar;201(1):137-41.
Zotero 插件